Lamisil description, usages, side effects, indications, overdosage, supplying and lots more!

Lamisil

Novartis Consumer Health, Inc.

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
Drug Facts

FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredient

Terbinafine hydrochloride

Purpose

Antifungal

Uses

  • cures most jock itch (tinea cruris) and ringworm (tinea corporis)
  • relieves itching, burning, cracking and scaling which accompany these conditions

Warnings

For external use only

Do not use

  • in or near the mouth or eyes
  • for vaginal yeast infections

When using this product

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop Use and ask doctor

if too much irritation occurs or gets worse

Keep Out of Reach of Children

If swallowed, get medical help or contact a poison control center right away.

Directions

  • adults and children 12 years and over:
    • use the tip of the cap to break the seal and open the tube
    • wash the affected skin with soap and water and dry completely before applying
    •  apply once a day (morning  or  night) for 1 week or as directed by a doctor
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

  • do not use if seal on tube is broken or is not visible
  • store at controlled room temperature 20-25°C (68-77°F)

Inactive ingredients

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions

call 1-800-452-0051

Novartis Consumer Health, Inc.

Parsippany, NJ 07054-0622 ©2008

Principal Display

Principal Display

Lamisil

TERBINAFINE HYDROCHLORIDE CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0067-3999
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TERBINAFINE HYDROCHLORIDE Terbinafine 10 mg

Inactive Ingredients

Ingredient Name Strength
BENZYL ALCOHOL
CETYL ALCOHOL
cetyl palmitate
ISOPROPYL MYRISTATE
POLYSORBATE 60
water
SODIUM HYDROXIDE
SORBITAN MONOSTEARATE
stearyl alcohol

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 TUBE
2 15 in 1 TUBE
3 NDC:0067-3999-15 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020980 2006-12-08


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.